managing avelumab side effects in patients with merkel cell carcinoma
Published 7 years ago • 724 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
1:08
dr. kaufman on avelumab in merkel cell carcinoma
-
1:28
avelumab treatment in patients with metastatic merkel cell carcinoma
-
2:18
durable responses to avelumab in patients with merkel cell carcinoma
-
1:18
dr. nghiem on challenges with immunotherapy in merkel cell carcinoma
-
1:03
role of immunotherapy in merkel cell carcinoma
-
0:35
dr. kudchadkar on the fda approval of avelumab in merkel cell carcinoma
-
1:37
dr. kaufman discusses durable responses to avelumab in merkel cell carcinoma
-
0:42
dr. kudchadkar on immunotherapy in merkel cell carcinoma
-
5:55
targetting pd-l1 with avelumab in metastatic merkel cell carcinoma
-
1:38
dr. lebbe discusses efficacy of avelumab in merkel cell carcinoma
-
1:43
dr. nghiem on immunotherapy in merkel cell carcinoma
-
1:19
dr. nghiem on response to immunotherapy in merkel cell carcinoma
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma transcript
-
1:36
avelumab and pembrolizumab for the treatment of merkel cell carcinoma
-
1:34
javelin merkel 200: avelumab for metastatic merkel cell carcinoma
-
2:03
avelumab in merkel cell carcinoma – updates from asco 2017
-
27:10
update in medical treatment of merkel cell carcinoma
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma
-
57:21
clinical utility of a novel assay for tracking tumor burden in merkel cell carcinoma